(Q35599469)

9 August 2017

1 reference

title

Pharmacologic management of psychosis in the elderly: a critical review (English)

1 reference

9 August 2017

1 reference

Nicholas Hoeh

1

1 reference

9 August 2017

Laszlo Gyulai

series ordinal

2

1 reference

9 August 2017

Daniel Weintraub

series ordinal

3

1 reference

9 August 2017

Joel Streim

series ordinal

4

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Journal of Geriatric Psychiatry and Neurology

9 August 2017

published in

1 reference

9 August 2017

volume

16

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

213-218

1 reference

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Schizophrenia in late life: findings challenge traditional concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Clozapine therapy for older veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Risperidone: treatment response in adult and geriatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Treatment of bipolar disorder in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Psychotic symptoms in Parkinson's disease patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Risk factors for nursing home placement in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Olanzapine treatment for dopaminergic-induced hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Donepezil in the treatment of hallucinations and delusions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Overview of depression and psychosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Long-Term use of quetiapine in elderly patients with psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

Efficacy and Tolerability of Olanzapine in Elderly Patients with Psychotic Disorders: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988703258663

21 January 2018

Identifiers

DOI

10.1177/0891988703258663

1 reference

release_2ttplrm7uvg5vgu237ikk5psia

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2ttplrm7uvg5vgu237ikk5psia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference